[Elective percutaneous coronary intervention after acute coronary syndrome]

Drazen Sebetić1, Miroslav Raguz, Ivana Sakić

  • 1Cardiovascular Division, University Department of Medicine, Dubrava University Hospital, Zagreb, Croatia.

Insights

Elective percutaneous coronary intervention (PCI) is recommended for acute coronary syndrome (ACS) patients with persistent ischemia or significant blockages. PCI improves symptoms, exercise tolerance, and reduces residual ischemia, aligning with ESC and AHA/ACC guidelines.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Context:

  • Guidelines from the European Society of Cardiology (ESC) and American Heart Association/American College of Cardiology (AHA/ACC) define indications for elective percutaneous coronary intervention (PCI).
  • PCI is a key therapeutic strategy following acute coronary syndrome (ACS).

Purpose:

  • To outline the indications and success criteria for elective PCI in ACS patients based on current guidelines.
  • To highlight the benefits of PCI in managing myocardial ischemia and coronary artery stenosis.

Summary:

  • Elective PCI is indicated for ACS patients with ST-segment elevation myocardial infarction (STEMI) experiencing persistent ischemia or significant stenosis suitable for intervention.
  • For non-ST-segment elevation ACS (NSTEMI), elective coronary angiography is recommended for low-risk patients with positive noninvasive ischemia tests, followed by PCI if indicated.
  • PCI is also considered for non-culprit significant coronary artery stenosis identified during primary PCI for STEMI.

Impact:

  • Successful PCI leads to earlier symptom resolution and improved clinical outcomes.
  • PCI enhances patient effort tolerance and reduces the rate of residual ischemia detected by noninvasive tests.
  • The success of PCI is evaluated through angiographic, clinical, and periprocedural assessments.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...